C-11 Raclopride
Showing 1 - 25 of >10,000
Obesity, Healthy Volunteers, Overweight Trial run by the NIDDK ([c11] raclopride, [18F]fallypride)
Active, not recruiting
- Obesity
- +2 more
- [c11] raclopride
- [18F]fallypride
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 30, 2022
Depression, Psychosis, Anhedonia Trial in Chapel Hill (Transdermal Estradiol, Micronized Progesterone, Matching Placebo Patch)
Recruiting
- Depression
- +2 more
- Transdermal Estradiol
- +3 more
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Dec 20, 2022
Traumatic Brain Injury Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (tDCS, [11C] Raclopride)
Recruiting
- Traumatic Brain Injury
- tDCS
- [11C] Raclopride
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
Diabetes, Type 2 Trial in Tuebingen (intranasal insulin, Placebo)
Recruiting
- Diabetes Mellitus, Type 2
- intranasal insulin
- Placebo
-
Tuebingen, GermanyUniversity of Tuebingen, Department of Internal Medicine IV
Jun 24, 2021
Cocaine Dependence Trial in New Haven (Methylphenidate, Alpha Methyl Para Tyrosine (AMPT), [11C]PHNO)
Terminated
- Cocaine Dependence
- Methylphenidate
- +3 more
-
New Haven, ConnecticutConnecticut Mental Health Center
Feb 24, 2021
Eating Disorder Trial in San Diego ([11C]raclopride, [11C]DASB, amphetamine)
Completed
- Eating Disorder
- [11C]raclopride
- +2 more
-
San Diego, CaliforniaUniversity of California San Diego
Apr 7, 2020
Cocaine Use Disorder Trial in Pittsburgh (Baseline [C-11]NPA PET Scan, d-amphetamine, Post-amphetamine [C-11]NPA PET Scan)
Recruiting
- Cocaine Use Disorder
- Baseline [C-11]NPA PET Scan
- +2 more
-
Pittsburgh, PennsylvaniaUniversity of PIttsburgh
Jun 27, 2022
Alcohol Use Disorder Trial in Pittsburgh ([C-11], NOP-1A)
Completed
- Alcohol Use Disorder
- [C-11]
- NOP-1A
-
Pittsburgh, PennsylvaniaUniversity of PIttsburgh PET Facility
Jul 8, 2022
Inflammation in Alzheimer's Disease and Related Dementias Using
Recruiting
- Alzheimer Disease
-
Saint Louis, MissouriWashington University School of Medicine
Nov 9, 2023
Carcinoid Syndrome, Metastatic Nonfunctional Well Differentiated Neuroendocrine Tumor Trial in Detroit (other, procedure, drug)
Recruiting
- Carcinoid Syndrome
- Metastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm
- Carbon C 11 Alpha-methyltryptophan
- +3 more
-
Detroit, MichiganWayne State University/Karmanos Cancer Institute
Mar 30, 2022
Mitral Valve Regurgitation Trial in Birmingham ([11C] acetate)
Recruiting
- Mitral Valve Regurgitation
- [11C] acetate
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jun 9, 2022
Tauopathies Trial in Philadelphia (drug, diagnostic test, behavioral)
Active, not recruiting
- Tauopathies
- 11C-HY-2-15 PET
- +3 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Sep 6, 2023
Ketoses, Metabolic Trial (Observational heart and kidney on siemens TEP scan)
Completed
- Ketoses, Metabolic
- Observational heart and kidney on siemens TEP scan
-
Sherbrooke, Quebec, CanadaResearch Center on Aging
Jan 16, 2023
11C-para-aminobenzoic Acid
Recruiting
- Renal Excretion
- +3 more
- 11C-para-aminobenzoic acid PET/CT
- Probenecid
-
Baltimore, MarylandJohns Hopkins Medical Institutions
Jan 30, 2023
Glioblastoma Multiforme Trial in Brno (11C-Methionine PET/CT)
Recruiting
- Glioblastoma Multiforme
- 11C-Methionine PET/CT
-
Brno, Czech Republic, CzechiaMasaryk Memorial Cancer Institute
Nov 3, 2022
Crohn's Disease Trial in Stockholm (AZD7798, [11C]AZ14132516)
Not yet recruiting
- Crohn's Disease
-
Stockholm, SwedenResearch Site
Sep 22, 2023
OMAR Opioid Use Disorder
Not yet recruiting
- Healthy Control
- Opioid Use Disorder
- (no location specified)
Jan 3, 2023
ALS Trial ([11C]CPPC PET ligand)
Not yet recruiting
- ALS
- [11C]CPPC PET ligand
- (no location specified)
Jan 9, 2023
Muscarinic Receptor Occupancy Trial in New Haven (Scopolamine, [11C]EMO ([11C]LSN3172176))
Not yet recruiting
- Muscarinic Receptor Occupancy
- Scopolamine
- [11C]EMO ([11C]LSN3172176)
-
New Haven, ConnecticutYale University
Aug 31, 2023
Melanoma Trial in Chapel Hill, Raleigh (FDG PET/CT scan, C11-AMT PET scan, Pembrolizumab)
Active, not recruiting
- Melanoma
- FDG PET/CT scan
- +3 more
-
Chapel Hill, North Carolina
- +1 more
Jan 10, 2023
Diabetes, Type 2, Heart Failure, Healthy Trial in Aarhus N (3-[11C]-OHB)
Recruiting
- Diabetes Mellitus, Type 2
- +2 more
- 3-[11C]-OHB
-
Aarhus N, Jutland, DenmarkAarhus University Hospital
Nov 1, 2022
CNS Tumor, Head and Neck Tumors Trial in Memphis (L-(11C) methionine)
Available
- Central Nervous System Tumor
- Head and Neck Neoplasms
- L-(11C) methionine
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 19, 2022